Literature DB >> 34791100

Regulation of AKT Signaling in Mouse Uterus.

Vijay K Sirohi1, Theresa I Medrano1, Ana M Mesa1, Athilakshmi Kannan2, Indrani C Bagchi2, Paul S Cooke1.   

Abstract

17β-estradiol (E2) treatment of ovariectomized adult mice stimulates the uterine PI3K-AKT signaling pathway and epithelial proliferation through estrogen receptor 1 (ESR1). However, epithelial proliferation occurs independently of E2/ESR1 signaling in neonatal uteri. Similarly, estrogen-independent uterine epithelial proliferation is seen in adulthood in mice lacking Ezh2, critical for histone methylation, and in wild-type (WT) mice treated neonatally with estrogen. The role of AKT in estrogen-independent uterine epithelial proliferation was the focus of this study. Expression of the catalytically active phosphorylated form of AKT (p-AKT) and epithelial proliferation were high in estrogen receptor 1 knockout and WT mice at postnatal day 6, when E2 concentrations were low, indicating that neither ESR1 nor E2 are essential for p-AKT expression and epithelial proliferation in these mice. However, p-AKT levels and proliferation remained estrogen responsive in preweaning WT mice. Expression of p-AKT and proliferation were both high in uterine luminal epithelium of mice estrogenized neonatally and ovariectomized during adulthood. Increased expression of phosphorylated (inactive) EZH2 was also observed. Consistent with this, Ezh2 conditional knockout mice show ovary-independent uterine epithelial proliferation and high epithelial p-AKT. Thus, adult p-AKT expression is constitutive and E2/ESR1 independent in both model systems. Finally, E2-induced p-AKT expression and normal uterine proliferation did not occur in mice lacking membrane (m)ESR1, indicating a key role for membrane ESR1 in AKT activation. These findings emphasize the importance of AKT activation in promoting uterine epithelial proliferation even when that proliferation is not E2/ESR1 dependent and further indicate that p-AKT can be uncoupled from E2/ESR1 signaling in several experimental scenarios.
© The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  cell proliferation; estrogen; estrogen receptor 1; membrane steroid receptors; protein kinase; uterine epithelium

Mesh:

Substances:

Year:  2022        PMID: 34791100      PMCID: PMC8667855          DOI: 10.1210/endocr/bqab233

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  58 in total

1.  PRL antiapoptotic effect in the rat decidua involves the PI3K/protein kinase B-mediated inhibition of caspase-3 activity.

Authors:  C Tessier; A Prigent-Tessier; S Ferguson-Gottschall; Y Gu; G Gibori
Journal:  Endocrinology       Date:  2001-09       Impact factor: 4.736

Review 2.  AKT as a Therapeutic Target for Cancer.

Authors:  Mengqiu Song; Ann M Bode; Zigang Dong; Mee-Hyun Lee
Journal:  Cancer Res       Date:  2019-02-26       Impact factor: 12.701

3.  Requirement of estrogen receptor-alpha in insulin-like growth factor-1 (IGF-1)-induced uterine responses and in vivo evidence for IGF-1/estrogen receptor cross-talk.

Authors:  Diane M Klotz; Sylvia Curtis Hewitt; Paolo Ciana; Michele Raviscioni; Jonathan K Lindzey; Julie Foley; Adriana Maggi; Richard P DiAugustine; Kenneth S Korach
Journal:  J Biol Chem       Date:  2001-12-21       Impact factor: 5.157

4.  Physiological coupling of growth factor and steroid receptor signaling pathways: estrogen receptor knockout mice lack estrogen-like response to epidermal growth factor.

Authors:  S W Curtis; T Washburn; C Sewall; R DiAugustine; J Lindzey; J F Couse; K S Korach
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

5.  Nature of functional estrogen receptors at the plasma membrane.

Authors:  Ali Pedram; Mahnaz Razandi; Ellis R Levin
Journal:  Mol Endocrinol       Date:  2006-04-27

6.  Stromal estrogen receptors mediate mitogenic effects of estradiol on uterine epithelium.

Authors:  P S Cooke; D L Buchanan; P Young; T Setiawan; J Brody; K S Korach; J Taylor; D B Lubahn; G R Cunha
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

7.  Neonatal uterine and vaginal cell proliferation and adenogenesis are independent of estrogen receptor 1 (ESR1) in the mouse.

Authors:  Manjunatha K Nanjappa; Theresa I Medrano; Amelia G March; Paul S Cooke
Journal:  Biol Reprod       Date:  2015-02-04       Impact factor: 4.285

8.  Membrane-localized estrogen receptor α is required for normal organ development and function.

Authors:  Ali Pedram; Mahnaz Razandi; Michael Lewis; Stephen Hammes; Ellis R Levin
Journal:  Dev Cell       Date:  2014-05-27       Impact factor: 12.270

Review 9.  FGF/FGFR signaling in health and disease.

Authors:  Yangli Xie; Nan Su; Jing Yang; Qiaoyan Tan; Shuo Huang; Min Jin; Zhenhong Ni; Bin Zhang; Dali Zhang; Fengtao Luo; Hangang Chen; Xianding Sun; Jian Q Feng; Huabing Qi; Lin Chen
Journal:  Signal Transduct Target Ther       Date:  2020-09-02

10.  WNK1 regulates uterine homeostasis and its ability to support pregnancy.

Authors:  Ru-Pin Alicia Chi; Tianyuan Wang; Chou-Long Huang; San-Pin Wu; Steven L Young; John P Lydon; Francesco J DeMayo
Journal:  JCI Insight       Date:  2020-11-19
View more
  3 in total

1.  A Causal Link Between Disrupted AKT Signaling and Hyperproliferative Endometrial Diseases.

Authors:  James K Pru
Journal:  Endocrinology       Date:  2022-03-01       Impact factor: 4.736

Review 2.  Estradiol and Estrogen-like Alternative Therapies in Use: The Importance of the Selective and Non-Classical Actions.

Authors:  Szidónia Farkas; Adrienn Szabó; Anita Emőke Hegyi; Bibiána Török; Csilla Lea Fazekas; Dávid Ernszt; Tamás Kovács; Dóra Zelena
Journal:  Biomedicines       Date:  2022-04-06

3.  EZH2 and Endometrial Cancer Development: Insights from a Mouse Model.

Authors:  Xin Fang; Nan Ni; Xiaofang Wang; Yanan Tian; Ivan Ivanov; Monique Rijnkels; Kayla J Bayless; John P Lydon; Qinglei Li
Journal:  Cells       Date:  2022-03-07       Impact factor: 7.666

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.